Clinical Research Directory
Browse clinical research sites, groups, and studies.
PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc
Sponsor: British Columbia Cancer Agency
Summary
This pilot clinical trial aims to assess the real world quality of life and survival of patients treated with targeted therapy that has preliminary evidence of efficacy in subjects with advanced rare cancers or cancer harbouring rare molecular aberrations. The treatment has been granted conditional or full approved by Health Canada (HC) as effective and safe. Due to the rarity of the cancer or molecular aberration the uncertainty level of the health technology assessment (HTA) by the pan Canadian Oncology Review (pCODR) was too high for consideration of funding or it was not submitted for consideration. Consequently, the goal of this study is to generate real world evidence to support HTA decision making throughout the life cycle of the product.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2021-06-30
Completion Date
2028-05-01
Last Updated
2025-09-25
Healthy Volunteers
No
Conditions
Interventions
QOL
QOL assessments using the ESAS, CPC, EQ5D every 4-8 weeks +/- 2 weeks
CT imaging
CT radiographic imaging every 12 weeks +/- 2 weeks
Locations (1)
BC Cancer
Vancouver, British Columbia, Canada